Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

430 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late-stage rehabilitation after anterior cruciate ligament reconstruction: A multicentre randomised controlled trial (PReP).
Niederer D, Keller M, Schüttler KF, Schoepp C, Petersen W, Best R, Mengis N, Mehl J, Krause M, Jakob S, Wießmeier M, Vogt L, Pinggera L, Guenther D, Ellermann A, Efe T, Groneberg DA, Behringer M, Stein T. Niederer D, et al. Among authors: jakob s. Ann Phys Rehabil Med. 2024 May;67(4):101827. doi: 10.1016/j.rehab.2024.101827. Epub 2024 Mar 12. Ann Phys Rehabil Med. 2024. PMID: 38479249 Clinical Trial.
Quadriceps and hamstring anterior cruciate ligament reconstruction differ only marginally in function after the rehabilitation: a propensity score-matched case-control study.
Niederer D, Keller M, Jakob S, Petersen W, Mengis N, Vogt L, Guenther D, Brandl G, Drews BH, Behringer M, Groneberg DA, Stein T. Niederer D, et al. Among authors: jakob s. Knee Surg Sports Traumatol Arthrosc. 2023 Aug;31(8):3441-3453. doi: 10.1007/s00167-023-07422-y. Epub 2023 Apr 30. Knee Surg Sports Traumatol Arthrosc. 2023. PMID: 37120794 Free PMC article.
Correction: The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. Buetti N, et al. Intensive Care Med. 2024 Apr 8. doi: 10.1007/s00134-024-07415-6. Online ahead of print. Intensive Care Med. 2024. PMID: 38587556 No abstract available.
Effects of IV fluid restriction according to site-specific intensity of standard fluid treatment-protocol.
Sivapalan P, Kaas-Hansen BS, Meyhoff TS, Hjortrup PB, Kjær MN, Laake JH, Cronhjort M, Jakob SM, Cecconi M, Nalos M, Ostermann M, Malbrain MLNG, Møller MH, Perner A, Granholm A. Sivapalan P, et al. Among authors: jakob sm. Acta Anaesthesiol Scand. 2024 Apr 4. doi: 10.1111/aas.14423. Online ahead of print. Acta Anaesthesiol Scand. 2024. PMID: 38576165 Free article.
The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. Buetti N, et al. Intensive Care Med. 2024 Mar 18. doi: 10.1007/s00134-024-07348-0. Online ahead of print. Intensive Care Med. 2024. PMID: 38498170
The authors reply.
Pölkki A, Moser A, Raj R, Takala J, Bendel S, Jakob SM, Reinikainen M. Pölkki A, et al. Among authors: jakob sm. Crit Care Med. 2024 Apr 1;52(4):e217-e218. doi: 10.1097/CCM.0000000000006205. Epub 2024 Mar 14. Crit Care Med. 2024. PMID: 38483239 No abstract available.
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial.
Tirupakuzhi Vijayaraghavan BK, Granholm A, Myatra SN, Jha V, Hammond N, Micallef S, Munch MW, Kjær MN, Møller MH, Lange T, Perner A, Venkatesh B; COVID-STEROID 2 collaborators. Tirupakuzhi Vijayaraghavan BK, et al. Lancet Reg Health Southeast Asia. 2023 Oct 4;20:100293. doi: 10.1016/j.lansea.2023.100293. eCollection 2024 Jan. Lancet Reg Health Southeast Asia. 2023. PMID: 38234702 Free PMC article.
430 results